Page 2 - Oliverr Baumann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oliverr baumann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oliverr Baumann Today - Breaking & Trending Today

VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline

Xlife Sciences AG / Key word: Mergers & Acquisitions/Takeover

VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline
29-Dec-2023 / 17:45 CET/CEST

Release of an ad hoc. ....

Christoph Antz , Oliverr Baumann , Synimmune Gmb , Xlife Sciences , Synimmune Gmbh , Acute Myeloid Leukemia , Acute Myeloid , Shareholders Meeting , Year Report ,

VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline - adhoc - Börsennachrichten

Xlife Sciences AG Key word Mergers & AcquisitionsTakeover VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline 29Dec2023 1745 CETCEST Release of an ad hoc announcement pursuant to ....

Synimmune Gmb , Christoph Antz , Oliverr Baumann , Xlife Sciences , Synimmune Gmbh , Acute Myeloid Leukemia , Acute Myeloid , Shareholders Meeting , Year Report ,

Xlife Sciences AG Achieves Significant Milestone in the Development of Radiodiagnostics for Liver Diseases

Xlife Sciences AG Achieves Significant Milestone in the Development of Radiodiagnostics for Liver Diseases
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

Oliverr Baumann , Xlife Sciences , European Union , Shareholders Meeting , Year Report ,

Xlife Sciences AG paves the way for the next successful out-licensing and announces cooperation with

Xlife Sciences AG / Key word(s): Letter of Intent/PartnershipXlife Sciences AG paves the way for the next successful out-licensing and announces cooperation with Quant Biomarkers AG for the development of advanced biomarkers for kidney diseases 20.12.2023 / 07:00 CET/CESTXlife Sciences AG (SIX: XLS) and Quant Biomar. ....

Dennis Fink , Sanja Baumann Tomovska , Oliverr Baumann , Clinical Research Department , Swiss Exchange , University Hospital Basel , Stock Exchange , Hvidovre University Hospital , Letter Of Intent Partnership , Xlife Sciences , Xlife Sciences Ag Key , Quant Biomarkers , Shareholders Meeting , Year Report ,

Revolutionary AI Algorithm «Prostate.Carcinoma.ai» Achieves EU MDR Class IIa Registration

Xlife Sciences AG / Key word: Regulatory Approval

Revolutionary AI Algorithm «Prostate.Carcinoma.ai» Achieves EU MDR Class IIa Registration
18-Dec-2023 / 07:00 CET/CEST

Release of an. ....

Oliverr Baumann , Matthias Steffen , Xlife Sciences , Prostate Carcinoma , Shareholders Meeting , Year Report ,